Can a phone app ease suicidal thoughts in young adults?

NCT ID NCT07767604

First seen Aug 17, 2026 ยท Last updated Aug 17, 2026

Summary

This trial tests whether an 8-week mobile health program called MindBridge, delivered through a WeChat mini-program and based on dialectical behavior therapy, can reduce suicide-related thoughts and behaviors in Chinese young adults aged 18 to 24 who are at mild-to-moderate risk. Participants are randomly assigned to receive MindBridge plus usual care or a general well-being program plus usual care. The study measures changes in suicidal thoughts, depression, anxiety, sleep, and other factors over the intervention and a month after.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
MindBridge, an 8-week mobile health intervention delivered via a WeChat mini-program, based on dialectical behavior therapy (DBT), added to treatment as usual.
What this could lead to
If effective, MindBridge could offer a scalable, accessible digital tool to help reduce suicide-related thoughts and behaviors in young adults.
What could go wrong
This is a small, early-stage trial (84 participants) with a behavioral intervention, so results may not generalize. The app is an add-on, not a replacement for standard care, and its benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jiangsu Medical College

    Yancheng, Jiangsu, 224005, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.